Manama : The National Health Regulatory Authority (NHRA) has approved Wegovy (semaglutide) pills, an oral GLP-1 treatment for obesity, in Bahrain, reflecting the authority’s commitment and that of the national healthcare system to keeping pace with the latest therapeutic advances and providing patients with access to advanced treatment options. The NHRA said the approval forms [...]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.